Clinically relevant dosing and pharmacokinetics of DNA-encoded antibody therapeutics in a sheep model.

antibody gene transfer electroporation oncology plasmid – gene delivery sheep

Journal

Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867

Informations de publication

Date de publication:
2022
Historique:
received: 12 08 2022
accepted: 14 09 2022
entrez: 20 10 2022
pubmed: 21 10 2022
medline: 21 10 2022
Statut: epublish

Résumé

DNA-encoded delivery and

Identifiants

pubmed: 36263202
doi: 10.3389/fonc.2022.1017612
pmc: PMC9574358
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1017612

Informations de copyright

Copyright © 2022 Hollevoet, Thomas, Compernolle, Vermeire, De Smidt, De Vleeschauwer, Smith, Fisher, Dewilde, Geukens and Declerck.

Déclaration de conflit d'intérêts

Authors TS and PF are employees of Inovio Pharmaceuticals and as such receives salary and benefits, including ownership of stock and stock options, from the company. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The authors declare that this study received funding from Inovio Pharmaceuticals under a sponsored research agreement. The funder had the following involvement with the study: contribution to study design and materials, interpretation of data, review of the article, and decision to submit it for publication.

Références

iScience. 2022 Aug 19;25(8):104705
pubmed: 35813873
Gene Ther. 2001 Aug;8(16):1264-70
pubmed: 11509960
J Immunol. 2020 Aug 1;205(3):648-660
pubmed: 32591390
Nat Rev Rheumatol. 2022 Mar;18(3):126
pubmed: 35132239
Sci Rep. 2020 Nov 11;10(1):19532
pubmed: 33177564
Cancer Gene Ther. 2022 Jul;29(7):984-992
pubmed: 34754076
Br J Cancer. 2018 Mar 6;118(5):679-697
pubmed: 29438365
J Transl Med. 2017 Jun 7;15(1):131
pubmed: 28592330
Lancet. 2015 Nov 21;386(10008):2078-2088
pubmed: 26386540
J Clin Invest. 2020 Feb 3;130(2):827-837
pubmed: 31697648
Oncotarget. 2018 Feb 6;9(17):13623-13636
pubmed: 29568382
Nat Biotechnol. 2013 Jul;31(7):647-52
pubmed: 23728362
J Biomed Sci. 2020 Jan 2;27(1):1
pubmed: 31894001
Emerg Microbes Infect. 2020 Dec;9(1):1523-1533
pubmed: 32579067
N Engl J Med. 2022 Aug 4;387(5):397-407
pubmed: 35921449
Mol Ther. 2019 May 8;27(5):974-985
pubmed: 30962164
Gut. 2018 May;67(5):818-826
pubmed: 28450388
J Hematol Oncol. 2022 Jan 15;15(1):6
pubmed: 35033167
Gastroenterology. 2015 Jun;148(7):1320-9.e3
pubmed: 25724455
Hum Vaccin Immunother. 2013 Oct;9(10):2246-52
pubmed: 24051434
Nature. 2018 Dec;564(7735):S16-S17
pubmed: 30542196
Hum Gene Ther. 2019 Nov;30(11):1431-1443
pubmed: 31382777
Curr Gene Ther. 2016;16(2):98-129
pubmed: 27029943
Cell Rep. 2018 Nov 13;25(7):1982-1993.e4
pubmed: 30428362
Cancer Gene Ther. 2021 Aug;28(7-8):828-838
pubmed: 32733055
Hum Gene Ther. 2021 Oct;32(19-20):1200-1209
pubmed: 34482757
Expert Opin Drug Deliv. 2016;13(2):295-310
pubmed: 26578324
Mol Ther. 2020 Apr 8;28(4):1068-1077
pubmed: 32101701
Nat Commun. 2017 Mar 02;8:14630
pubmed: 28251988
BioDrugs. 2020 Jun;34(3):273-293
pubmed: 32157600
Mol Ther. 2004 Mar;9(3):328-36
pubmed: 15006599

Auteurs

Kevin Hollevoet (K)

PharmAbs, The KU Leuven Antibody Center - University of Leuven, Leuven, Belgium.
Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven - University of Leuven, Leuven, Belgium.

Debby Thomas (D)

PharmAbs, The KU Leuven Antibody Center - University of Leuven, Leuven, Belgium.
Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven - University of Leuven, Leuven, Belgium.

Griet Compernolle (G)

PharmAbs, The KU Leuven Antibody Center - University of Leuven, Leuven, Belgium.
Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven - University of Leuven, Leuven, Belgium.

Giles Vermeire (G)

Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven - University of Leuven, Leuven, Belgium.

Elien De Smidt (E)

PharmAbs, The KU Leuven Antibody Center - University of Leuven, Leuven, Belgium.
Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven - University of Leuven, Leuven, Belgium.

Stéphanie De Vleeschauwer (S)

Laboratory Animal Center, KU Leuven - University of Leuven, Leuven, Belgium.

Trevor R F Smith (TRF)

Inovio Pharmaceuticals, San Diego, CA, United States.

Paul D Fisher (PD)

Inovio Pharmaceuticals, San Diego, CA, United States.

Maarten Dewilde (M)

PharmAbs, The KU Leuven Antibody Center - University of Leuven, Leuven, Belgium.
Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven - University of Leuven, Leuven, Belgium.

Nick Geukens (N)

PharmAbs, The KU Leuven Antibody Center - University of Leuven, Leuven, Belgium.

Paul Declerck (P)

PharmAbs, The KU Leuven Antibody Center - University of Leuven, Leuven, Belgium.
Laboratory for Therapeutic and Diagnostic Antibodies, KU Leuven - University of Leuven, Leuven, Belgium.

Classifications MeSH